These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 213744

  • 21. Clinical trials of immunosuppression and immunomodulation in multiple sclerosis.
    Kappos L.
    J Neuroimmunol; 1988 Dec; 20(2-3):261-8. PubMed ID: 3058744
    [Abstract] [Full Text] [Related]

  • 22. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
    Staugaitis SM, Shapshak P, Myers LW, Ellison GW, Tourtellotte WW, Lee M.
    Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
    [Abstract] [Full Text] [Related]

  • 23. Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire.
    Hommes OR, Weiner HL.
    J Neurol Sci; 2004 Aug 15; 223(1):65-7. PubMed ID: 15261563
    [Abstract] [Full Text] [Related]

  • 24. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O, Fernández V, De Ramón E.
    J Neurol Sci; 2004 Aug 15; 223(1):29-34. PubMed ID: 15261557
    [Abstract] [Full Text] [Related]

  • 25. T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?
    Henneberg A, Fischer EG, Kornhuber HH.
    Eur Arch Psychiatry Neurol Sci; 1988 Aug 15; 238(2):94-6. PubMed ID: 2850189
    [Abstract] [Full Text] [Related]

  • 26. [Immunsuppressive treatment of multiple sclerosis. 2. Critical review of general results (author's transl)].
    Frick E, Angstwurm H, Strauss G.
    MMW Munch Med Wochenschr; 1974 Nov 08; 116(45):1987-92. PubMed ID: 4216803
    [No Abstract] [Full Text] [Related]

  • 27. Immunosuppressive therapy. 2.
    Skinner MD, Schwartz RS.
    N Engl J Med; 1972 Aug 10; 287(6):281-6. PubMed ID: 4556903
    [No Abstract] [Full Text] [Related]

  • 28. The peculiar difficulties of therapeutic trials for multiple sclerosis.
    Myers LW, Ellison GW.
    Neurol Clin; 1990 Feb 10; 8(1):119-41. PubMed ID: 1690838
    [Abstract] [Full Text] [Related]

  • 29. [Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H.
    Monatsschr Kinderheilkd (1902); 1972 Jun 10; 120(6):249-51. PubMed ID: 4115641
    [No Abstract] [Full Text] [Related]

  • 30. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH.
    Curr Med Res Opin; 2007 Jun 10; 23(6):1199-208. PubMed ID: 17559719
    [Abstract] [Full Text] [Related]

  • 31. [Therapeutic measures in multiple sclerosis].
    Harrer G.
    Wien Med Wochenschr; 1980 Oct 15; 130(19):620-4. PubMed ID: 6256981
    [No Abstract] [Full Text] [Related]

  • 32. Immunosuppressive treatment of multiple sclerosis.
    Schweitzer SF.
    J Neurosurg Nurs; 1985 Aug 15; 17(4):256-9. PubMed ID: 2993548
    [Abstract] [Full Text] [Related]

  • 33. Immunosuppressive drugs in rheumatoid arthritis.
    Currey HL.
    Mod Trends Rheumatol; 1971 Aug 15; 2():174-98. PubMed ID: 4344785
    [No Abstract] [Full Text] [Related]

  • 34. [Cyclophosphamide changes oligoclonal immunoglobulin G spectrum in cerebrospinal fluid in slowly progressing multiple sclerosis].
    Ochudło S, Wajgt A.
    Neurol Neurochir Pol; 1996 Aug 15; 30(1):7-16. PubMed ID: 8657352
    [Abstract] [Full Text] [Related]

  • 35. [Immunosuppressive treatment in multiple sclerosis].
    Oliveira TV, Gorz-Reinhardt AM, Gracia CM, Bittencourt PR.
    Arq Neuropsiquiatr; 1992 Sep 15; 50(3):295-301. PubMed ID: 1308406
    [Abstract] [Full Text] [Related]

  • 36. The treatment of multiple sclerosis.
    Kott HS.
    Med Clin North Am; 1972 May 15; 56(3):711-6. PubMed ID: 4338391
    [No Abstract] [Full Text] [Related]

  • 37. Drug treatment of inflammatory bowel disease.
    Lennard-Jones JE, Powell-Tuck J.
    Clin Gastroenterol; 1979 Jan 15; 8(1):187-217. PubMed ID: 33775
    [No Abstract] [Full Text] [Related]

  • 38. Results of an international questionnaire on immunosuppressive treatment of multiple sclerosis.
    Hommes OR, Weiner HL.
    Mult Scler; 2002 Apr 15; 8(2):139-41. PubMed ID: 11990871
    [Abstract] [Full Text] [Related]

  • 39. [Selected methods of current treatment of multiple sclerosis].
    Orłowska E.
    Neurol Neurochir Pol; 1980 Apr 15; 14(3):321-5. PubMed ID: 6158011
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].
    Patzold U, Haller P, Haas J, Pocklington P, Deicher H.
    Nervenarzt; 1978 May 15; 49(5):285-94. PubMed ID: 673085
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.